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Abstract
Family history of mental illness provides important information when evaluating pediatric bipolar
disorder (PBD). However, such information is often challenging to gather within clinical settings.
This study investigates the feasibility and utility of gathering family history information using an
inexpensive method practical for outpatient settings. Families (N=273) completed family history,
rating scales, MINI and KSADS interviews about youths 5–18 (median=11) years presenting to an
outpatient clinic. Primary caregivers completed a half page Family Index of Risk for Mood issues
(FIRM). All families completed the FIRM quickly and easily. Most (78%) reported 1+ relatives
having history of mood or substance issues, M=3.7 (SD=3.3). A simple sum of familial mood
issues discriminated cases with PBD from all other cases, AUROC=.63, p=.006. FIRM scores
were specific to youth mood disorder and not ADHD or disruptive behavior disorder. FIRM scores
significantly improved the detection of PBD even controlling for rating scales. No subset of family
risk items performed better than the total. Family history information showed clinically
meaningful discrimination of PBD. Two different approaches to clinical interpretation showed
validity in these clinically realistic data. Inexpensive and clinically practical methods of gathering
family history can help to improve the detection of PBD.
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Bipolar disorder is a highly heritable condition, with both strong genetic (Smoller & Finn,
2003) and environmental contributions (Tsuchiya, Byrne, & Mortensen, 2003) to the risk of
illness. Because of this, identifying a family history of mood disorder can be helpful in
clarifying the diagnostic formulation for youths (Hodgins, Faucher, Zarac, & Ellenbogen,
2002; Youngstrom & Duax, 2005), who often show ambiguous clinical presentations
(Axelson et al., 2006; Lewinsohn, Klein, & Seeley, 2000; Youngstrom, 2009). Family
history of bipolar disorder has been recommended as a key piece of evidence to be included
in actuarial and evidence based approaches for assessing bipolar disorder (Quinn & Fristad,
2004; Youngstrom, Findling, Youngstrom, & Calabrese, 2005). Based on meta-analyses of
at-risk youths who have a parent with bipolar disorder, a history of bipolar disorder is
associated with at least a five-fold increase in risk for the youth developing bipolar
(Hodgins, et al., 2002). Family history of mood disorder—and of bipolar disorder in
particular—is useful information for clinicians who are trying to assess risk of bipolar
disorder in youths and to weigh and interpret ambiguous clinical presentations. In much the
same way, practitioners in other areas of medicine already are using family history, in
combination with other established risk factors such as smoking or obesity, to improve
clinical assessment and promote early identification of illnesses such as heart disease or
cancer (Guyatt & Rennie, 2002).
However, despite the potential utility of family history information, it is often difficult to
gather in a systematic fashion. Complicating factors include: a general failure to collect
standardized family history as a part of standard practice (Garb, 1998), the expense and
cumbersome nature of available semi-structured interviews (Andreasen, Endicott, Spitzer, &
Winokur, 1977; Nurnberger et al., 1994; Weissman et al., 2000), the potential for families to
be unaware of formal diagnoses or perhaps to have been misdiagnosed (DelBello, Lopez-
Larson, Soutullo, & Strakowski, 2001; Neighbors, Trierweiler, Ford, & Muroff, 2003;
Strakowski et al., 1997; Strakowski et al., 2003), and the frequent lack of availability of
fathers and other relatives for direct interview. These factors often compel clinicians to rely
on mothers to provide collateral family history during the evaluation of youths.
There are different strategies to collect information about family history. These approaches
can be categorized broadly as the family history and family study methods. The family
history method is a simple report about the presence of specific diseases or various disorders
from one family member about another (Andreasen, Endicott, Spitzer, & Winokur, 1977;
Andreasen, Rice, Endicott, Reich, & Coryell, 1986; Baker, Berry, & Adler, 1987;
Thompson, Orvaschel, Prusoff, & Kidd, 1982). In contrast, the family study method requires
the direct clinical assessment of all members of the family. This strategy has higher validity
because the diagnosis is more accurate, but it has a markedly higher cost; and it may not be
possible for all family members, as some may be unreachable or even deceased (Hardt &
Franke, 2007). Whereas the family study method would have the greatest internal validity
for research purposes, the family history method more closely approximates what would be
typically done in clinical practice, and thus has greater generalizability.
There is a growing consensus in the field that having at least some information about family
history is better than not having any (Birmaher et al., 2009; Geller et al., 2006; Hardt &
Franke, 2007; Wozniak, Biederman, Mundy, Mennin, & Faraone, 1995). Also, family
history about more severe conditions appears to have greater validity than family history
about less severe diseases (Hardt & Franke, 2007).
On the other hand, once the data about family history have been collected, the next question
is what to do with them? Different scoring strategies have been proposed to optimize the use
of this information. Approaches range from a simple dichotomization--family history
present/absent--to a more complex scoring mechanism that takes into account the density of
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the disorder (i.e., the number of family members who have the disorder; Milne et al., 2008).
There is some evidence that density scores have greater predictive validity than the
dichotomous score. The observed number of family members with a positive history of
disorder is considered the best strategy with disorders with low or moderate prevalence,
such as suicide, or bipolar disorder (Milne, et al., 2008).
The goal of the present investigation was to determine the feasibility of gathering family
history of mood disorders and related conditions, balancing the competing goals of being
clinically meaningful yet sufficiently inexpensive and low-burden to be well tolerated. This
study also tested the validity of this index of family history as a risk factor for pediatric
bipolar disorder, both by evaluating the discriminative validity of family history as a
predictor of youth diagnoses of bipolar disorder, and also by examining the discriminative
validity with regard to diagnoses of attention-deficit/hyperactivity disorder (ADHD) in
youths. Also, we studied the accuracy of components of the family history index compared
to a structured diagnostic interview, a “family study” method of capturing the diagnoses of
specific relatives.
Our first hypothesis was that the family history would show predictive value for identifying
youths with bipolar spectrum disorder. A second hypothesis was that the association with
bipolar disorder would be significantly stronger than for other disorders that are commonly
comorbid with bipolar disorder, such as ADHD.
A third hypothesis was that family history, when ascertained using a form that could be
readily implemented into clinical practice, would contribute incremental value in the
assessment of potential bipolar disorder above and beyond using established mood
checklists completed by the same informant.
Finally, we predicted that family history would show significant agreement with diagnostic
information collected with a structured diagnostic interview. We predicted only low to
moderate kappa values when comparing family history checklist ratings to structured
diagnostic interviews about specific relatives, for several reasons: (a) agreement about
bipolar diagnoses is typically low when comparing clinical diagnoses to structured
diagnostic interviews, with a recent meta-analysis finding K < .1 (Rettew, Lynch,
Achenbach, Dumenci, & Ivanova, 2009); (b) mood diagnoses are especially prone to be
misdiagnosed as a psychotic or antisocial disorder in minorities (DelBello, et al., 2001;
Neighbors, et al., 2003; Strakowski, et al., 2003), who are over-represented in the present
sample, and (c) the risk measure is asking for people’s recall of clinical diagnoses, which is
prone to error (Weissman, et al., 2000) and also influenced to an unknown extent by
differences in how families conceptualize mood and behavior problems (Li, Silverman,
Smith, & Zaccario, 1997).
Method
Participants
Inclusion criteria—The Institutional Review Board (IRB) of the University Hospitals
Case Medical Center and the IRB of Applewood Centers, Inc. (Cleveland, OH) both
approved the procedures. Enrolled participants were youth ages 5–18 years old and their
primary caregivers seeking outpatient evaluation for the youth. All caregivers gave written
informed consent and all youth gave written assent.
Exclusion criteria—Families needed to be able to complete questionnaires and interviews
in English.
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Demographics and Diagnostic Presentation—Participants were 273 families
presenting for outpatient evaluation of their youth at either an urban community mental
health center or an academic outpatient clinic. Families were mostly low-income, with 90%
making less than $40,000 per year, and a median reported income of less than $15,000 for
the primary caregiver. A high school diploma or GED was the median level of education.
Seventy five percent of adult informants were biological mothers, 4% were biological
fathers, and the remaining 21% of informants consisted of a variety of other relationships,
including grandparents (5.9%), aunts or uncles (3.3%), or foster parents (0.4%). Youths
were mostly male (n = 173, 63%), African American (n = 187, 68%), with an average age of
10.3 (SD = 3.6) years.
Diagnostically, 43 youths (16%) were on the bipolar spectrum. Of these, 3 met criteria for
bipolar I, 6 for bipolar II, 15 for cyclothymic disorder, and 19 for bipolar NOS. These cases
were 56% male, ranged in age from 5 to 17 years (M = 10.6, SD = 4.0), and racially diverse:
42% identified as African American, 33% as European American, 9% as Hispanic, and 16%
as “Other.” Diagnoses that are frequently difficult to discern from pediatric bipolar disorder
were highly prevalent in the full sample: 64% of youths had ADHD, 41% had oppositional-
defiant disorder (ODD), 31% had a unipolar depressive disorder, and 11% had conduct
disorder (CD). In the full sample, the median number of axis I diagnoses was 4.0, and 4.8 in
the cases with bipolar disorder.
Measures
Parents completed a battery of mood and behavior checklists that included the Mood
Disorder Questionnaire-Parent version (P-MDQ; Wagner et al., 2006). The P-MDQ is a 13-
item scale designed to screening bipolar disorder with a Cronbach’s alpha of .82 in the
present sample, and an AUROC = .82 for discriminating youths with bipolar versus all other
cases.
Embedded at the end of the P-MDQ was the Family Index of Risk for Mood (FIRM). The
FIRM contains a total of 25 checkboxes that consist of an array of questions about mental
health history (suicide, depression, mania, hospitalization, or substance use) for each of
several relatives (caregiver’s grandparents, parents, aunts/uncles, siblings, or children). The
FIRM score consisted of the sum of items endorsed for established risk factors related to
bipolar disorder. A copy of the FIRM is appended, and it is available for use by the
readership. Separate scores also could count the density of family loading for each type of
pathology (i.e., percentage of relatives affected with each type of disorder). Internal
consistency, commonly measured by Cronbach’s alpha, does not appear to be a meaningful
concept for this type of instrument (Cicchetti et al., 2006). For example, an uncle’s
hospitalization would not necessarily be expected to correlate with a sibling’s suicidal
ideation.
Parents also completed the 2001 version of the Child Behavior Checklist (CBCL;
Achenbach & Rescorla, 2001), one of the most widely used instruments in research and
clinical work involving child and adolescent mental health. The CBCL includes 118
problem behavior items rated from 0 (not at all typical of the child) to 2 (often typical of the
child). The present study concentrated on the Externalizing Score (8 day test-retest
reliability r = .92, alpha = .94; Achenbach & Rescorla, 2001).
Finally, caregivers also completed the 10 item Mania Scale version of the Parent General
Behavior Inventory (PGBI-10M; Youngstrom, Frazier, Demeter, Calabrese, & Findling,
2008). This brief instrument has demonstrated excellent psychometric properties, with a
Cronbach’s alpha of .92, a one month retest reliability of .62, and an AUROC = .85 for
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discriminating youths with bipolar versus all other cases, similar to an alpha of .93 and
AUROC = .83 for the full-length version of the PGBI.
Youth diagnoses—Formal diagnoses were made based on an expert review consensus
process including the results of an interview using the Schedule for Affective Disorders and
Schizophrenia for School-Age Children Present and Lifetime Version (KSADS-PL;
Kaufman et al., 1997) supplemented with the mood modules from the Washington
University version to gather additional information about mood symptoms and suicidality
(Geller et al., 2001). Highly trained research assistants conducted all semi-structured
interviews with an item level κ ≥ 0.85 (details about training are provided in an earlier
preliminary publication; Youngstrom et al., 2005). Interviewers met with the caregiver and
the youth sequentially, re-interviewing each as necessary to resolve reporting discrepancies
using clinical judgment. A licensed psychologist reviewed the interviews and assigned final
consensus diagnoses, blind to scores on the rating scales. Diagnoses followed the DSM-IV
criteria (American Psychiatric Association, 2001). Bipolar disorder not otherwise specified
(NOS) typically resulted from youths not showing at least one-week durations of mania or
four-day durations of hypomanic episodes, rather than having an insufficient number of
manic symptoms or low intensity of symptoms. In order to conform with DSM criteria, we
did not require elated mood or grandiosity (as would be necessary for the research definition
of the narrow phenotype; Leibenluft, Charney, Towbin, Bhangoo, & Pine, 2003). However,
more than 85% of families reported clear occurrences of one or the other, even though
irritable mood and aggression were more commonly perceived as the presenting problem.
Adult diagnoses—The relative that brought the youth for evaluation completed a direct
interview about their own mental health history, and they repeated the same interview to
report on the mental health history of the other biological parent(s) based on The Mini-
International Neuropsychiatric Interview (MINI; Sheehan et al., 1998). The MINI is a brief,
fully-structured diagnostic interview that assesses 17 Axis I disorders, antisocial personality,
and suicidality according to DSM-IV criteria. Interviews typically were 15 to 20 minutes per
person. The MINI has demonstrated good validity, with median kappas > .63 against other
interviews, and inter-rater reliabilities ranging from kappa of .79 to 1.00 (Sheehan et al.).
Procedure
Families completed the informed consent and assent and then worked with an interview
team. One interviewer conducted the KSADS. The other interviewer supervised
questionnaire completion and conducted the MINI with the caregiver while the youth was
doing the KSADS. Diagnostic interviews were blind to the questionnaire results.
Data Analyses
Descriptive analyses evaluated distributions against the assumptions for each the proposed
analyses. Receiver Operating Characteristic (ROC) analyses quantified the sensitivity and
specificity across the full range of possible scores, yielding an Area Under the ROC
(AUROC) value where 1.00 would indicate perfect performance and .50 would indicate
chance performance of the FIRM when discriminating cases with versus without a bipolar
spectrum disorder. A t test compared the difference between AUROCS to establish whether
one test performed significantly better than the other (Hanley & McNeil, 1983). Logistic
regression tested whether the FIRM score provided significant incremental improvement in
the prediction of bipolar disorder after controlling for other screening tools. Kappa
coefficients quantified the agreement of the FIRM scores about specific relatives with
corresponding diagnoses based on the MINI.
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Descriptive Analyses of the Family Index of Risk for Mood
Families completed the FIRM quickly and without difficulty, despite caregivers’ highly
variable education levels. Eighty-nine percent completed the FIRM without any questions,
and only three needed the instrument read to them. There were virtually no missing data on
the FIRM (99.9% complete).
When comparing responses from biological mothers versus all other relatives, children
accompanied by their mother tended to be slightly younger (p = .04), but showed no other
significant demographic or diagnostic differences. Mood scores did not differ significantly
either, but biological mothers tended to report more family history of mental health
problems than other relatives, (t = 2.20, p = .02), consistent with the belief that mothers may
be better informed historians than other relatives (Richters, 1992).
The most commonly endorsed family issue in the full sample was “alcohol/drug problems,”
reported for at least one relative in 62% of families, followed by “depression problems” in
58% of families, “manic or bipolar” in 42% of families, “mental health hospitalization” in
37% of families, and suicide in 23% of the families. Twenty-two percent of families did not
endorse even one risk factor. Of the families who endorsed one or more risk factors (78%),
the mean number of risk factors endorsed was 3.7 (SD = 3.3).
Hypothesis 1: Family Index of Risk for Mood will be Associated with Pediatric Bipolar
Diagnoses
The FIRM total score was significantly higher when the youths had pediatric bipolar
diagnoses versus for the rest of families. Except for “alcohol/drug problems,” the family risk
subscores also were significantly higher in the bipolar group. Effect sizes ranged between
Cohen’s d = .13 to d = .52; see Table 1.
The number of family risk factors (a simple sum of the number of checks) discriminated
cases with research diagnoses of pediatric bipolar disorder from all other cases, AUROC=.
63, p = .006. No subset of family risk items performed better than the total. Family history
of mania showed essentially identical performance, AUROC = .60, p = .035.
Hypothesis 2: Family Index of Risk for Mood will be Specific to Youth Diagnoses of Mood
Disorders
The FIRM total score did not show an association with the youth having a diagnosis of
ADHD, AUROC = .46, p = .355; ODD, AUROC = .50, p = .907; or CD, AUROC = .53, p
= .537. The association with bipolar diagnoses was significantly stronger than the
association with ADHD, ODD, or CD, z values > 2.3, p values <.01. Secondary analyses
indicated that the FIRM score was related to unipolar depression in the youths, AUROC = .
64, p < .0005, indicating that the FIRM score reflects risk for mood disorders generally, not
just bipolar disorder. When analyses were limited to those with mood disorders, no scales
discriminated between youths with unipolar depression versus bipolar disorders.
Hypothesis 3: FIRM Scores Will Have Incremental Value Above Screening Instruments for
Identifying Pediatric Bipolar Disorder
Logistic regressions evaluated whether the FIRM score remained a significant predictor of
bipolar diagnoses even after controlling for scores on screening instruments that have
previously demonstrated validity in this and other samples. FIRM scores provided a
significant improvement in the detection of bipolar cases, whether first adjusting for CBCL
Externalizing scores, P-MDQ scores, or PGBI-10M scores (all increments p < .05 for both
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FIRM Total and FIRM Mania scores, except for FIRM Total p = .070 after controlling for P-
MDQ). The regression weights ranged from .09 for the FIRM after controlling for P-MDQ
to .14 after controlling for CBCL Externalizing (p = .006), with a one point increase in the
FIRM score increasing the predicted odds ratio of the youth having bipolar disorder by 10%
to 15% after controlling for the checklist score. Checklist scores were always highly
significant, also making a unique incremental contribution to the prediction of bipolar
diagnoses. Detailed results are available as supplemental tables upon request from the
authors.
Clinical Decision Making with the Family Index of Risk for Mood
Although logistic regressions provide a good statistical model for evaluating predictors, they
are not a practical tool for clinicians to use in evaluating patients (Kraemer, 1992). For this
reason, we also evaluated two different approaches for integrating the FIRM into clinical
decision making. One approach would be to establish cut scores and report the diagnostic
efficiency statistics associated with each. When combining tests -- such as using the FIRM
in conjunction with the CBCL, P-MDQ, or PGBI-10M – the tests can be organized
sequentially or in tandem. Because the AUROC values for the FIRM by itself are lower than
the AUROC values for both externalizing scores on the CBCL (Youngstrom et al., 2004)
and the mania-specific measures such as the P-MDQ and PGBI-10M (Youngstrom et al.,
2005), it does not make sense to use the FIRM by itself or as a first line of assessment. Thus
we evaluated using FIRM scores as a second, follow-up or in tandem. A strategy of using
the family risk variable as a supplemental screening tool, and considering cases “test
positive” if they scored high on either the family risk index (scores of 8 or higher) or a
mania screen for the youth (e.g., 8 or more on a parent-completed MDQ) resulted in
improved diagnostic efficiency, with the algorithm yielding sensitivity of .58 and specificity
of .77, (LR+ = 2.47, LR− = 0.54), and a kappa of .26, p <.00005. Table 2 presents the
diagnostic efficiency statistics for the FIRM total score alone and in combination with either
the CBCL Externalizing score using a common “rule of thumb” of T > 70, or else in tandem
with a high score on a mania-specific checklist.
Careful study of Table 2 reveals several things. The number of cases scoring “positive” for
bipolar varied widely depending on the algorithm, from 7% to 60% in the present sample.
The kappa between the algorithm and the consensus diagnosis was significant for all
approaches (except those using the CBCL), but it was also always modest. The percentage
of “test positives” that actually have bipolar disorder was never higher than 50% in the
present sample, either. The last column in Table 2 uses Bayes’ Theorem to project what the
positive predictive value of the algorithm would be if it were used in a different setting
where bipolar disorder were more rare. As algebra dictates, making bipolar more rare means
that a smaller percentage of test positives will have bipolar disorder, further exacerbating the
modest performance of all the algorithms.
The second, newer approach involved estimating diagnostic likelihood ratios for different
levels of FIRM scores, which clinicians could then combine with other information about
the patient to arrive at a revised estimate of risk of bipolar disorder. This approach has been
developed in evidence-based medicine (Guyatt & Rennie, 2002) and has started to be
applied to other instruments for assessing pediatric bipolar disorder (Youngstrom, et al.,
2004; Youngstrom & Youngstrom, 2005). In the simple case where the base rate of bipolar
disorder is the only prior information available about risk and the FIRM score is the only
piece of information added, then the combination of these data points – whether via Bayes’
Theorem or a probability nomogram –is the positive predictive value. This approach is more
flexible than the older, multiple-test sequencing approach. Using the “multi-level” approach,
where likelihoods are estimated for multiple ranges of scores, milks more information from
the test result than a simple “high/low” dichotomization. The approach also allows
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combinations of tests that may not yet have been empirically evaluated together, and it also
enables projections of scenarios that will occur in clinical practice but may be too rare to
empirically examine with parametric statistics.
Table 3 presents the multi-level likelihood ratios for splitting FIRM scores into “low,”
“moderate,” and “high risk” scores, and then illustrates the resulting values when combining
these with a high score on a specific test (e.g., high score on the PGBI-10M). The pairing of
a high risk FIRM score and a high risk PGBI-10M score yielded an estimate of 69%
probability that the youth has a bipolar diagnosis, versus the closest analog estimate from
Table 2 being a 33% probability for a high FIRM score or a high PGBI-10M. The use of an
“or” strategy will always be less specific than an “and” strategy, allowing more false
positives (Guion, 1998; Youngstrom, Findling, & Calabrese, 2003). However, trying to
evaluate the “and” strategy using the multi-test sequencing approach would run aground as
the sample became too shallow to explore the combination of interest: only 7 cases scored
high on both measures, failing to meet Kraemer’s rule of thumb for evaluating a medical test
(Kraemer, 1992).
Validity Analyses
We studied the criterion validity of the scores collected from parents with the FIRM
(bipolar, unipolar depression, alcohol and substance abuse) as compared to MINI family
study method findings about relatives’ diagnoses. The kappa between parent’s FIRM and
MINI mania or hypomania was K = .23 (p < .00005); for depression, K = .26 (p < .00005).
For alcohol and substance abuse, kappas were .24 and .21 (p < .00005) respectively. When
the two approaches disagreed, the MINI identified more cases of bipolar than did the FIRM
by a ratio of 2.1 to 1, indicating that the FIRM was more specific than sensitive.
Discussion
The goal of this paper was to evaluate the clinical feasibility and utility of a short checklist
to gather information about familial risk for bipolar disorder. Based on the literature about
the lag in recognition of bipolar disorder (Hirschfeld, Lewis, & Vornik, 2003; Lish, Dime-
Meenan, Whybrow, Price, & Hirschfeld, 1994; Marchand, Wirth, & Simon, 2006) and the
frequency with which it goes undiagnosed or misdiagnosed, particularly in minorities
(DelBello, et al., 2001; Strakowski, et al., 2003), the tool included items assessing related
characteristics beyond the DSM-IV criteria for depression and mania. The brief family
history items were well tolerated by families, who answered all items and had little to no
difficulty with the reading level and organization of questions. When item scores pertaining
to bipolar, depression, and substance use were compared to the results of structured
diagnostic interviews for the same relatives, the FIRM showed modest sized but highly
significant kappas, consistent with the typical performance of brief family history measures
compared to direct interviews (Hardt & Franke, 2007; Roy, Walsh, & Kendler, 1996;
Weissman, et al., 2000). Also consistent with other measures, the FIRM was more likely to
omit cases identified by direct structured interview than to have false positives.
More importantly, the family history information showed a clinically meaningful association
with youth diagnoses of pediatric bipolar disorder (based on strict DSM-IV criteria, and
applied via a semi-structured diagnostic interview conducted by highly trained raters). The
association between family history and diagnosis appeared specific to mood disorders, and
was not associated with changes in risk of ADHD or disruptive behavior disorders. The
value of the FIRM score appeared similar for identifying those at risk of mood disorders
generally, rather that bipolar disorder specifically, although developing a clinical
interpretative framework for predicting depression falls outside the scope of this paper.
Results were consistent with the general pattern of findings from twin studies, where mood
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disorders show distinct heritability contributions from externalizing problems (Rende &
Waldman, 2006) or substance disorders (Kendler et al., 1995). The size of the relationship is
also comparable to established benchmarks based on reviews of studies looking at familial
risk (DelBello & Geller, 2001; Hodgins, et al., 2002): The diagnostic likelihood ratio of 2.5
for high scores on the FIRM is similar to the risk associated with confirmed bipolar disorder
in a second-degree relative, or a fuzzy history of bipolar (Youngstrom, et al., 2005).
In addition, the family history information provided incremental validity when predicting
bipolar diagnoses, even after controlling for other information provided by the same
informant. These analyses provided a strong test of the potential clinical value of adding the
FIRM to other assessment strategies. It also is worth noting that these results were found in a
sample that contained many characteristics likely to challenge a test’s performance. The
entire sample had serious enough problems to be seeking services, with high degrees of
comorbidity in both the youths and their families. The diagnoses most difficult to tease apart
from bipolar (Kim & Miklowitz, 2002) outnumbered the number of cases with bipolar
disorder. Furthermore, the majority of the bipolar cases had “spectrum” presentations that
often slip past screening tools (Miller, Klugman, Berv, Rosenquist, & Ghaemi, 2004) yet
appear to be the more common presentation according to epidemiological studies
(Merikangas & Pato, 2009; Van Meter, Moreira, & Youngstrom, 2011). Whereas effect
sizes typically shrink when moving from “efficacy” research designs that emphasize internal
validity into “effectiveness” settings that emphasize generalizability, the present findings are
“pre-shrunk” to the extent that the design incorporated many of the factors that would be
typically encountered in clinical applications.
It was interesting to find that the risk index did not improve as a predictor of pediatric
bipolar disorder when limited to family history of mania. This could be due to bipolar
disorder resulting from the accumulation of multiple nonspecific risk factors (Tsuchiya, et
al., 2003), or else due to the inaccuracy with which bipolar disorder has been recognized in
the past. This could be error in past diagnoses, or it could be the product of the mental health
literacy (Jorm, 2000) of the caregiver responsible for completing the FIRM. Overall, the
findings suggest that even inexpensive and highly simplified methods of gathering family
history can help to improve the detection of pediatric bipolar disorder.
Finally, we also investigated how the FIRM might be applied by clinicians, either alone or in
combination with other rating scales. We evaluated both a multiple-test sequence and a
newer, likelihood-ratio/Bayesian approach advocated by evidence based medicine.
Comparison of the two showed that the newer method is more flexible, gleaning more
information from the same tests than a simple “test positive/negative” decision, allowing
more choice in terms of test selection, and allowing projections to cases encountered in
clinical practice. These projections will not be perfect, and should be updated or superseded
as new data become available; but the Bayesian framework also provides a structure for
integrating these updates (Smith, Winkler, & Fryback, 2000) and for generating reasonable
estimates with imperfect inputs (Straus, Richardson, Glasziou, & Haynes, 2005). Using
these approaches is likely to improve the accuracy of decisions about diagnoses (Rettew, et
al., 2009), particularly about bipolar disorder in youths (Jenkins, Youngstrom, Washburn, &
Youngstrom, 2011). Our recommendation to clinicians would be to combine the FIRM with
whatever general intake assessment that they use, and combine the risk information from it
and any other risk factors or assessment scales using the nomogram approach to decide
whether the patient is low, medium, or high risk of bipolar disorder (Youngstrom, Freeman,
& Jenkins, 2009). Further assessment and treatment formulation would then proceed
accordingly.
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As mentioned above, one of the main limitations is that the present sample includes many
demographic and clinical characteristics that are likely to reduce the diagnostic performance
of the FIRM. It is likely that the performance of the FIRM would be different, and
potentially even better, in samples with a different composition (Zhou, Obuchowski, &
McClish, 2002). Test developers often use designs that create optimal performance for the
measure (Tillman & Geller, 2005), but the performance of these instruments can degrade
rapidly under clinically realistic conditions (Youngstrom, Meyers, Youngstrom, Calabrese,
& Findling, 2006). It also is possible that a more complicated scoring algorithm, using
customized weights for different relatives or varying clinical issues, might further improve
performance of the FIRM (Milne et al., 2008). However, these weights are also more likely
to be sample-dependent and to shrink upon cross-validation or application in clinical
settings. Most importantly, any family history measure is limited by the knowledge of the
informant. For example adopted children, or mothers who are unaware of the paternal side
of the family, will not have the same historical information available. Also, lack of a
reported family history does not equate to lack of a family history, due to all of the factors
that can undermine the validity of any one person’s knowledge of a given family’s history.
Clinical Implications and Future Directions
Future research should study how the FIRM and the interpretive approach might apply to
other clinical issues, such as depression or ADHD. Studies should also investigate the extent
to which education or cultural factors might change the performance of the FIRM, as well as
the role of other factors such as family conflict as predictors in their own right. It is
reassuring that other evidence-based assessment recommendations have remained robust
when generalized to new demographic groups and clinical settings (Jenkins, Youngstrom,
Youngstrom, Feeny, & Findling, 2011). Another important angle of study would be whether
different family members agree when completing the FIRM, and whether it is possible to
select which perspective would have the greatest informational value (Vandeleur et al.,
2008).
Present results suggest that the FIRM could be applied as part of a comprehensive
assessment approach for pediatric bipolar disorder. It is low cost and low burden enough to
be practical in most clinical settings, and it has demonstrated incremental value even under
clinically realistic conditions. A vignette included in the appendices illustrates how the
FIRM score might be integrated with other information within this evidence-based medicine
framework to support flexible but accurate evaluation of bipolar disorder in youths.
Although a direct family interview would be more accurate (and would yield more powerful
information), the FIRM is user friendly and stands a good chance of being implemented in
settings where a direct interview may not be possible. On the other hand, the FIRM is not a
good proxy for direct interviews of family members when family history is the main focus,
consistent with the findings for other family history screens (Li et al., 1997). Clinicians who
are familiar with genograms may want to draw one with the family before asking the parent
to complete the FIRM, as this process has increased the yield of useful family history
information in other studies (Baker, et al., 1987).
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Appendix I. Family Index of Risk for Mood (FIRM)
Please indicate whether any of your (blood) relatives have had any of these concerns: other than
the child in
this study
Grandparents Parents Aunts/Uncles Brothers/Sisters Children
Suicide □ □ □ □ □
Alcohol/Drug Problems □ □ □ □ □
Mental Hospital □ □ □ □ □
Depression Problems □ □ □ □ □
Manic or Bipolar □ □ □ □ □
Has a health professional ever told you that you have manic-depressive illness or bipolar disorder? Yes No
Appendix II Vignette Illustrating the Use of the Family Index of Risk for
Mood as Part of a Clinical Evaluation
Lena is a 12 year old African American girl who was evaluated in a community mental
health center for concerns about her social and emotional functioning. She has been doing
more poorly in school this past fall and is extremely irritable and argumentative at home. In
order to gain some context for the problems that worried her family and the school staff,
Lena’s mother sought an outpatient mental health evaluation. As part of the standard intake
procedure, the mother completed the CBCL Achenbach scale and the Family Index of Risk
for Mood issues (FIRM), the brief family screen described in the article. The CBCL
indicated a T score of 70 on the Externalizing Problem Scale, reflecting a clinically elevated
level of aggressive and rule-breaking behavior compared to other girls of similar age. The
total FIRM score was 12, due to heavy family history of severe problems -- including
suicide, bipolar and drug/alcohol history in an uncle.
At this early stage, the clinician has not spent any additional time with the family, nor have
they added any additional assessment tools or evaluations. There are three key pieces of
information relevant to Lena’s probability of having a bipolar spectrum disorder: (a) that her
problems are bringing her to an outpatient clinic; (b) the elevated CBCL Externalizing score;
and (c) the FIRM score. Depending on the setting, between 5 and 15% of new referrals to
outpatient mental health clinics are likely to be on the bipolar spectrum. The clinician elects
to start with a 6% probability, based on published recommendations and on their recent
pattern of referrals. The clinician decides to use the recommended evidence-based medicine
procedure – a probability nomogram – to integrate the initial screening results. Based on
published benchmarks, the CBCL Externalizing score increases the likelihood of a bipolar
disorder by 1.5 times, and the FIRM score increases the likelihood by 2.5 times. Combining
these pieces of information using a probability nomogram (http://www.cebm.net/
index.aspx?o=1043) (Guyatt & Rennie, 2002; Youngstrom & Duax, 2005; Youngstrom,
Freeman, & Jenkins, 2009) yields a combined probability of 19% -- bipolar disorder may
not be likely, but there are warning signs that warrant further investigation. Diagnostic
likelihood ratios are changes in the odds of a diagnosis, not linear changes in probability of
the diagnosis. The probability nomogram saves the clinician several steps when compared to
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calculating the change in probability directly. The algebraic steps involved would be (a)
convert the prior probability to prior odds; (b) multiply the odds by the diagnostic likelihood
ratio of the test or risk factor, and then (c) converting the revised odds back into a
probability. When more than one diagnostic likelihood ratio is available simultaneously, it is
more convenient to multiply the diagnostic likelihood ratios and then enter the product in the
nomogram or calculator, versus iterating through the steps sequentially with each likelihood
ratio; algebraically the final result will be the same.
The clinician decides to have the mother complete a specialized mania scale, the Parent
General Behavior Inventory-Mania 10 Item version (Youngstrom, et al., 2008). This is also
brief and in the public domain, again taking little time and adding no cost to the evaluation.
The score comes back a 19, highly elevated. Consulting with the benchmarks shows that this
increases the likelihood of a bipolar disorder by 7.5, substantially more worrisome than the
score on the CBCL. Recommended practice is to focus on the single most relevant score
from any rating scales gathered from the same person. Thus the PGBI-10M replaces the
CBCL for the purpose of evaluating potential bipolar disorder. The clinician then combines
the base rate of bipolar in outpatient settings (6%) with the likelihoods attached to high
FIRM (2.5) and high PGBI-10M scores (7.5). Using a nomogram or probability calculator
arrives at an estimate of 54% revised probability of a bipolar spectrum disorder. This alerts
the clinician that detailed evaluation of the possibility of a bipolar disorder is justified,
although the available information is not sufficient to justify pharmacological intervention
without further assessment. At this stage, inexpensive screening tools have helped identify
risk factors and focus attention on priorities for further assessment.
The clinician reviews the FIRM results in detail with the mother and learns that Lena’s
father and grandmother suffered unipolar depression and substance abuse problems in the
past, and one of Lena’s brothers is actually in treatment after being diagnosed as having
bipolar II. The clinician chooses to replace the information about the family history from the
FIRM score with the information about the bipolar II in the brother. A confirmed history of
bipolar disorder in a first-degree relative is linked with at least a 5.0 increase in likelihood.
Consulting the nomogram one last time results in a revised probability of 70% (6% base rate
combined with 7.5 likelihood from the PGBI-10M, and 5.0 likelihood from the brother’s
bipolar II diagnosis).
This example illustrates how information can be integrated, and rapid choices made about
how to upgrade information and re-evaluate, without adding much time or expense to
existing procedures. At this point, a direct discussion can be had about the costs and benefits
of different treatment options and more intensive assessment strategies. In Lena’s case, a
careful semi-structured interview revealed that she met criteria for DSM-IV diagnoses of
cyclothymic disorder and comorbid ADHD. Lena and her family agreed to begin
psychotherapy as a first line strategy, focused on mood monitoring, emotion regulation, and
family-focused therapy (Youngstrom, Van Meter, & Algorta, 2010). A difficult decision
remains to be solved about the incorporation of a pharmacological strategy for Lena’s
ADHD. The family agreed to a stimulant trial in combination with a daily life chart to track
Lena’s mood and energy while also monitoring potential side effects.
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Table 1
Family Index of Risk for Mood issues (FIRM) scores for families of youths with bipolar spectrum diagnoses
compared to rest of outpatient mental health sample




Mann Whitney z value Cohen’s d
Suicide 0.2 (0.5) 0.5 (0.7) 2.71** .44
Alcohol/Drug 1.1 (1.2) 1.3 (1.2) .95 .13
Mental Hospitalizations 0.4 (0.7) 0.7 (1.0) 2.07* .41
Depression 1.0 (1.1) 1.6 (1.4) 2.72** .49
Manic 0.6 (0.9) 1.1 (1.3) 2.37** .49







p < .005; significance tests based on nonparametric Mann-Whitney because of high skew; Cohen’s d based on pooled SDs; conventional
benchmarks for d are .2 for small, .5 for medium, and .8 for large effects.
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